CD4 and neoplasm: Similar as before the reduced frequency of CD4+ Tregs in B16SLC35A1 tumors was concomitant with increased IFN-γ production by infiltrating lymphocytes, indicating a shift from T cell tolerance towards T cell immunity that sets stage early after tumor implantation (Figure 2C).